The Effect of Probiotics in Stroke Treatment

Table 4

Meta-analysis for continuous variables.

Effect index	Detail index	Studies included	Heterogeneity test	Model	MD (95% CI)
Effect on stroke	NIHSS score	2 [20, 31]	I^2 = 93%,	Random effects model	−1.11 (−7.92, 5.70),
	Hospital stay duration	5 [17, 21, 23, 24, 29]	I^2 = 81%,	Random effects model	−8.94 (−11.39, −6.50),
	Bedrest duration	3 [17, 24, 29]	I^2 = 0%,	Fixed effects model	−10.34 (−11.30, −9.39),
Blood nutrition indicators	HB	7 [12, 16, 21, 25, 26, 30, 31]	I^2 = 51%,	Fixed effects model	8.36 (6.34, 10.38),
	ALB	9 [12, 16, 21, 23, 25, 27, 30, 31]	I^2 = 54%,	Random effects model	2.91 (2.45, 3.37),
	TP	6 [16, 21, 25, 27, 31]	I^2 = 82%,	Random effects model	4.90 (2.43, 7.38),
	PA	4 [12, 16, 27, 31]	I^2 = 74%,	Random effects model	15.50 (9.2, 21.79),
Inflammation indicators	TNF-α	3 [14, 21, 26]	I^2 = 78%,	Random effects model	−3.22 (−5.61, −0.82),
	IL-6	2 [21, 26]	I^2 = 0%,	Fixed effects model	−16.40 (−21.97, −10.83),
	IL-10	2 [14, 23]	I^2 = 0%,	Fixed effects model	−6.63 (−12.55, −0.70), P = 0.03
	hs-CRP	2 [14, 23]	I^2 = 0%,	Fixed effects model	−2.82 (−10.10, 4.47),
	PCT	2 [14, 23]	I^2 = 0%,	Fixed effects model	−0.35 (−2.58, 1.89),